Insulin-like growth factor binding protein-6 released from human mesenchymal stem cells confers neuronal protection through IGF-1R-mediated signaling

Human bone marrow-derived mesenchymal stem cells (hMSCs) are a desirable cell source for cell-based therapy to treat nervous system injuries due to their ability to differentiate into specific cell types. In addition to their multi-potency, hMSCs render the tissue microenvironment more favorable for...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Hyo-Jin, Park, Jihye, Shin, Joo-Hyun, Chang, Mi-Sook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716453/
https://www.ncbi.nlm.nih.gov/pubmed/29039467
http://dx.doi.org/10.3892/ijmm.2017.3173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716453/
https://www.ncbi.nlm.nih.gov/pubmed/29039467
http://dx.doi.org/10.3892/ijmm.2017.3173

Ejemplares similares